# 2026-10321: FDA to Review Moderna mRNA Flu Vaccine Safety Data

2026-10321, Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc., is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-22, effective 2026-06-18; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-10321
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-10321
- Title: Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc.
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 30309
- Published: 2026-05-22
- Effective: 2026-06-18
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA to Review Moderna mRNA Flu Vaccine Safety Data

## Summary

The FDA is holding a public meeting on June 18, 2026, to talk about the safety and effectiveness of MFLUSIVA, a new flu vaccine made by Moderna. Anyone can watch online and share their thoughts before June 17. This is a big deal for people who get flu shots and could affect how this vaccine is used and approved.

## Abstract

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.

## Effects PRIA read

- Advisory Review of Moderna mRNA Flu Vaccine: benefit, medium. If you are 50 years of age or older, FDA's advisory committee will meet on June 18, 2026 to discuss the safety and effectiveness of MFLUSIVA (an mRNA influenza vaccine manufactured by Moderna) for preventing influenza A and B. The public docket for comments (Docket No. FDA-2026-N-4162) closes June…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-10321 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/22/2026-10321/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a)
- [2026-10321 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-22/pdf/2026-10321.pdf)

## Related
- [Previous: 2026-10320, Caribbean Fishery Management Council's Outreach and Education Advisory Panel; P…](https://policyrisk.com/federal-register/2026-10320)
- [Next: 2026-10322, Magnuson-Stevens Act Provisions; General Provisions for Domestic Fisheries; App…](https://policyrisk.com/federal-register/2026-10322)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-10321 (as of 2026-06-08).
